The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

被引：0
|
作者：
Wong, Yu Jun [1 ]
Manejero, Fria May Gloriba [1 ]
Lim, Kim Wei [1 ]
Chong, Sin Yoong [1 ]
Mai, Linn War [1 ]
Kumar, Rahul [1 ]
Teo, Eng Kiong [1 ]
Tan, Jessica [1 ]
Hsiang, John Chen [2 ]
Thurairajah, Prem Harichander [1 ]
机构：
[1] Changi Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
[2] Sengkang Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU354
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [41] Hepatitis C treatment outcomes of HIV infected people who inject drugs in a real-world cohort
    Basoulis, D.
    Papadopoulou, M.
    Eliadi, I.
    Psichogiou, M.
    HIV MEDICINE, 2019, 20 : 298 - 298
  • [42] Impact of Daclatasvir-Sofosbuvir Combination Treatment on Medical Events and Costs in Patients Infected with Genotype 3 Hepatitis C Virus
    Gorsh, Boris
    Sill, Bruce E.
    Hede, Shalini
    Thibault, Catherine St-Laurent
    Moorjaney, Divya
    Ganz, Michael
    Kalsekar, Anupama
    Yuan, Yong
    HEPATOLOGY, 2015, 62 : 920A - 921A
  • [43] Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data
    Ishigami, Masatoshi
    Hayashi, Kazuhiko
    Honda, Takashi
    Kuzuya, Teiji
    Ishizu, Yoji
    Ishikawa, Tetsuya
    Nakano, Isao
    Urano, Fumihiro
    Kumada, Takashi
    Yoshioka, Kentaro
    Goto, Hidemi
    Hirooka, Yoshiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (11) : 1879 - 1886
  • [44] Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States
    Wong, R. J.
    Nguyen, M. T.
    Trinh, H. N.
    Huynh, A.
    Ly, M. T.
    Nguyen, H. A.
    Nguyen, K. K.
    Yang, J.
    Garcia, R. T.
    Levitt, B.
    da Silveira, E.
    Gish, R. G.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (01) : 17 - 21
  • [45] Sofosbuvir plus ribavirin for the treatment of hepatitis C virus genotype 2 in Korea: What's the optimal dosage of ribavirin in real-world setting?
    Yoon, Jae Hyun
    Jun, Chung Hwan
    Seo, Ji Ho
    Cho, Hyun A.
    Cho, Sung Bum
    Choi, Sung Kyu
    Cho, Ju Yeon
    Kim, Man Woo
    Lim, Sung Wook
    JOURNAL OF DIGESTIVE DISEASES, 2019, 20 (01) : 31 - 37
  • [46] Effectiveness of 8-or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naive, genotype 1 hepatitis C infected patients
    Curry, M. P.
    Tapper, E. B.
    Bacon, B.
    Dieterich, D.
    Flamm, S. L.
    Guest, L.
    Kowdley, K. V.
    Lee, Y.
    Milligan, S.
    Tsai, N.
    Younossi, Z.
    Afdhal, N. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (05) : 540 - 548
  • [47] Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
    Ghebremeskel, Ghirmay Ghebrekidan
    Solomon, Michael Berhe
    Achila, Oliver Okoth
    Mengistu, Samuel Tekle
    Asmelash, Rahel Frezghi
    Mesfin, Araia Berhane
    Hamida, Mohammed Elfatih
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
    Ghirmay Ghebrekidan Ghebremeskel
    Michael Berhe Solomon
    Oliver Okoth Achila
    Samuel Tekle Mengistu
    Rahel Frezghi Asmelash
    Araia Berhane Mesfin
    Mohammed Elfatih Hamida
    Scientific Reports, 13
  • [49] Real-world effectiveness of sofosbuvir and ledipasvir/sofosbuvir based regimens in hepatitis C virus genotype 3 infection within national hepatitis C elimination program in the country of Georgia
    Tsertsvadze, Tengiz
    Chkhartishvili, Nikoloz
    Abutidze, Akaki
    Sharvadze, Lali
    Kerashvili, Vakhtang
    Kamkamidze, George
    Zakalashvili, Mamuka
    Gvinjilia, Lia
    Nasrullah, Muazzam
    Gamkrelidze, Amiran
    Kvaratskhelia, Valeri
    Zeuzem, Stefan
    Arora, Sanjeev
    Thornton, Karla A.
    Afdhal, Nezam H.
    Averhoff, Francisco
    HEPATOLOGY, 2017, 66 : 627A - 628A
  • [50] Real-world effectiveness of sofosbuvir and ledipasvir/sofosbuvir based regimens in hepatitis C virus genotype 3 infection within national hepatitis C elimination program in the country of Georgia
    Tsertsvadze, T.
    Chkhartishvili, N.
    Sharvadze, L.
    Abutidze, A.
    Arora, S.
    Thornton, K.
    Kerashvili, V.
    Zhamutashvili, M.
    Ezugbaia, M.
    Svanidze, M.
    Darakhvelidze, M.
    Kvaratskhelia, V.
    Afdhal, N.
    Zeuzem, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S742 - S742
12345